Chu et al identified that TIGAR (TP53-induced glycolysis and apoptosis regulator) may be a predictive biomarker to guide esophageal squamous cell carcinoma treatment strategies in esophageal squamous cell carcinoma PDX.162. This evidence concerns the gene TIGAR and esophageal squamous cell carcinoma.